Hypertensive Herzkrankheit – zur Diagnoseist der Nachweis Einer Linksventrikulären Hypertrophie Nicht Nötig
Summary
Funding / potential competing interests
References
- Rimoldi, S.F.; Noll, G.; Allemann, Y. Hypertensive Herzkrankheit. Schweiz Med Forum. 2009, 9, 516520. [Google Scholar] [CrossRef]
- Lang, R.M.; et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2010, 11, 223–244. [Google Scholar] [CrossRef] [PubMed]
- Drazner, M.H. Contemporary review in cardiovascular Medicine. The progression of hypertensive heart disease. Circulation. 2011, 123, 327–334. [Google Scholar] [CrossRef] [PubMed]
- Barbieri, A.; Bursi, F.; Mantovani, F.; Vakenti, C.; Quaglia, M.; et al. Left ventricular hypertrophy reclassification and death: application of the recommendation of the American Society of Echocardiography/European Association of Echocardiography. EHJ Cardiovascular Imaging 2012, 13, 109–117. [Google Scholar] [CrossRef] [PubMed]
- Vegelati, R.S.; Gona, P.; Levy, D.; Aragam, J.; Larson, M.G.; et al. Relations of biomarkers representing distinct biological pathways to left ventricular geometry. Circulation. 2008, 118, 2252–2258. [Google Scholar]
- Goldberg, L.R.; Goldberg, M. Stage B heart failure. Management of asymptomatic left ventricular systolic dysfunction. Circulation. 2006, 113, 2851–2860. [Google Scholar] [PubMed]
- Masugata, H.; Senda, S.; Murao, K.; Okuyama, H.; Inukai, M.; et al. Association between echocardiographic paparameters and brain natriuretic peptide levels in treated hypertensive patients. Clin Exp Hypertens. 2011, 33, 187–191. [Google Scholar] [CrossRef] [PubMed]
- Salles, G.F.; Cardoso, C.R.; Fiszman, R.; Muxfeldt, E.S. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistent hypertension. Atherosclerosis. 2011, 216, 199–204. [Google Scholar] [CrossRef] [PubMed][Green Version]
- 9. Parati, G.; Stergiou, G.S.; Asmar, R.; Bilo, G.; de Leeuw, P.; et al.; on behalf of the ESH Working Group on Blood Pressure Monitoring European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertension. 2008, 26, 1505–1530. [Google Scholar] [CrossRef] [PubMed]
- Mancia, G.; Fagard, R.; Narkiewicz, K.; Redon, J.; Zanchetti, A.; et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013, 34, 2159–2219. [Google Scholar] [PubMed]
- Mor-Avi, V.; Lang, R.M.; Badano, L.P.; Belohlvek, M.; Cardim, N.M.; Derumeaux, G.; et al. Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications Endorsed by the Japanese Society of Echocardiography. Eur J Echocardiography. 2011, 12, 167–205. [Google Scholar]
© 2014 by the author. Attribution - Non-Commercial - NoDerivatives 4.0.
Share and Cite
Zuber, M.; Erne, P. Hypertensive Herzkrankheit – zur Diagnoseist der Nachweis Einer Linksventrikulären Hypertrophie Nicht Nötig. Cardiovasc. Med. 2014, 17, 37. https://doi.org/10.4414/cvm.2014.00222
Zuber M, Erne P. Hypertensive Herzkrankheit – zur Diagnoseist der Nachweis Einer Linksventrikulären Hypertrophie Nicht Nötig. Cardiovascular Medicine. 2014; 17(2):37. https://doi.org/10.4414/cvm.2014.00222
Chicago/Turabian StyleZuber, Michel, and Paul Erne. 2014. "Hypertensive Herzkrankheit – zur Diagnoseist der Nachweis Einer Linksventrikulären Hypertrophie Nicht Nötig" Cardiovascular Medicine 17, no. 2: 37. https://doi.org/10.4414/cvm.2014.00222
APA StyleZuber, M., & Erne, P. (2014). Hypertensive Herzkrankheit – zur Diagnoseist der Nachweis Einer Linksventrikulären Hypertrophie Nicht Nötig. Cardiovascular Medicine, 17(2), 37. https://doi.org/10.4414/cvm.2014.00222